| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 16, 2004
From Essen University, Department of Cardiology, Essen, Germany (M.H., N.D., A.S., D.B., H.E., T.N., M.G., H.W., R.E.); Medisch Spectrum Twente, Department of Cardiology, Enschede, the Netherlands (C.B., K.G.H.); and the Cardiovascular Research Foundation, New York, NY (G.S.M.). * To whom correspondence should be addressed. E-mail: von.birgelen{at}freeler.nl.
Background--Intravascular ultrasound (IVUS) is increasingly used as an end point in studies aimed at reducing progression or inducing regression of coronary artery disease. However, data linking serial changes by IVUS with clinical outcomes are scarce. Methods and Results--In the absence of a validated risk score for secondary prevention, we compared 3 established risk scores for primary prevention--PROCAM, SCORE, and Framingham--with plaque progression and lumen reduction as assessed with serial IVUS (follow-up, 18±9 months) in atherosclerotic left main coronary arteries of 56 patients with established atherosclerosis. For all 3 algorithms, patients at highest estimated risk of events showed greater plaque progression than patients at lowest risk (P<0.05 to <0.01). There were positive linear relationships between the risk of clinical events and plaque progression (r=0.41 to 0.60; P<0.002 to <0.0001). This translated into a greater decrease in lumen dimensions with increasing risk (P<0.05, PROCAM and SCORE). Risk prediction using the PROCAM algorithm showed the strongest relation with serial IVUS. During follow-up, 18 patients suffered from adverse cardiovascular events; these patients had an annual plaque progression that was significantly greater than other patients (25.2±19.4% versus 5.9±15.6%, P<0.001). Conclusions--There was a positive linear relationship between the estimated risk of clinical events derived from all 3 established risk-score algorithms and the extent of plaque progression measured by serial IVUS. This translated into stenosis progression (reduction in lumen dimensions) with increasing clinical risk.
Revised on May 12, 2004
Accepted on May 19, 2004
Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries
Clemens von Birgelen MD, PhD*,
This article has been cited by other articles:
![]() |
S. J. Lehman, C. L. Schlett, F. Bamberg, H. Lee, P. Donnelly, L. Shturman, M. F. Kriegel, T. J. Brady, and U. Hoffmann Assessment of Coronary Plaque Progression in Coronary Computed Tomography Angiography Using a Semiquantitative Score J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1262 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Philipp, D. Bose, W. Wijns, S. P. Marso, R. S. Schwartz, A. Konig, A. Lerman, H. M. Garcia-Garcia, P. W. Serruys, and R. Erbel Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry Eur. Heart J., October 23, 2009; (2009) ehp428v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V O Puntmann How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease Postgrad. Med. J., October 1, 2009; 85(1008): 538 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Hong, G. S. Mintz, S. W. Kim, S. Y. Lee, S. Y. Kim, T. Okabe, A. D. Pichard, L. F. Satler, R. Waksman, K. M. Kent, et al. Disease progression in nonintervened saphenous vein graft segments a serial intravascular ultrasound analysis. J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1257 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tobis and A. Perlowski Atheroma volume by intravascular ultrasound as a surrogate for clinical end points. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1116 - 1118. [Full Text] [PDF] |
||||
![]() |
C. von Birgelen and P. M.J. Verhorst Novel ultrasonic insight into coronary arteries Eur J Echocardiogr, November 1, 2008; 9(6): 713 - 714. [Full Text] [PDF] |
||||
![]() |
S. J. Nicholls, E. M. Tuzcu, S. Kalidindi, K. Wolski, K.-W. Moon, I. Sipahi, P. Schoenhagen, and S. E. Nissen Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling: A Pooled Analysis of 5 Intravascular Ultrasound Trials J. Am. Coll. Cardiol., July 22, 2008; 52(4): 255 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Han, J. H. Bae, D. R. Holmes Jr, R. J. Lennon, E. Eeckhout, G. W. Barsness, C. S. Rihal, and A. Lerman Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis Eur. Heart J., June 1, 2008; 29(11): 1359 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J.P. Kastelein and E. de Groot Ultrasound imaging techniques for the evaluation of cardiovascular therapies Eur. Heart J., April 1, 2008; 29(7): 849 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Brown A Direct Comparison of Intravascular Ultrasound and Quantitative Coronary Arteriography: Implications for Measures of Atherosclerosis as Clinical Surrogates Circulation, April 10, 2007; 115(14): 1824 - 1826. [Full Text] [PDF] |
||||
![]() |
J. H. Revkin, C. L. Shear, H. G. Pouleur, S. W. Ryder, and D. G. Orloff Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future Pharmacol. Rev., March 1, 2007; 59(1): 40 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. von Birgelen and M. Hartmann Coronary Plaque Burden and Cardiovascular Risk Factors: Single-Point Versus Serial Assessment J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1914 - 1915. [Full Text] [PDF] |
||||
![]() |
T. R Pedersen, G. Assmann, J.-P. Bassand, M J. Chapman, R. Erbel, and C. Sirtori Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment Diabetes and Vascular Disease Research, September 1, 2006; 3(2_suppl): S1 - S12. [Abstract] [PDF] |
||||
![]() |
M. Hartmann, C. von Birgelen, G. S. Mintz, M. G. Stoel, H. Eggebrecht, H. Wieneke, M. Fahy, T. Neumann, J. van der Palen, H. W. Louwerenburg, et al. Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries J. Am. Coll. Cardiol., August 1, 2006; 48(3): 446 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hartmann, C. von Birgelen, G. S. Mintz, P. M.J. Verhorst, and R. Erbel Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (>=12 months) follow-up Eur. Heart J., August 1, 2006; 27(15): 1778 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Tardif, T. Heinonen, D. Orloff, and P. Libby Vascular Biomarkers and Surrogates in Cardiovascular Disease Circulation, June 27, 2006; 113(25): 2936 - 2942. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Nicholls, E. M. Tuzcu, T. Crowe, I. Sipahi, P. Schoenhagen, S. Kapadia, S. L. Hazen, C.-C. Wun, M. Norton, F. Ntanios, et al. Relationship Between Cardiovascular Risk Factors and Atherosclerotic Disease Burden Measured by Intravascular Ultrasound J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1967 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. von Birgelen, M. Hartmann, G. S. Mintz, D. Bose, H. Eggebrecht, T. Neumann, M. Gossl, H. Wieneke, A. Schmermund, M. G. Stoel, et al. Remodeling Index Compared to Actual Vascular Remodeling in Atherosclerotic Left Main Coronary Arteries as Assessed With Long-Term (>=12 Months) Serial Intravascular Ultrasound J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1363 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Leineweber, D. Bose, M. Vogelsang, M. Haude, R. Erbel, and G. Heusch Intense Vasoconstriction in Response to Aspirate From Stented Saphenous Vein Aortocoronary Bypass Grafts J. Am. Coll. Cardiol., March 7, 2006; 47(5): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmermund, S. Achenbach, T. Budde, Y. Buziashvili, A. Forster, G. Friedrich, M. Henein, G. Kerkhoff, F. Knollmann, V. Kukharchuk, et al. Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months: A Multicenter, Randomized, Double-Blind Trial Circulation, January 24, 2006; 113(3): 427 - 437. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |